| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 54.831 | 297.180 | 142.131 |
| Total Income - EUR | - | - | - | - | - | - | - | 54.831 | 372.983 | 280.008 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 11.246 | 214.104 | 190.941 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 43.586 | 158.879 | 89.068 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 43.048 | 156.353 | 89.068 |
| Employees | - | - | - | - | - | - | - | 1 | 2 | 1 |
Check the financial reports for the company - Crab Ray Doc S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 17.262 | 17.184 | 33.170 |
| Current Assets | - | - | - | - | - | - | - | 161.081 | 485.686 | 233.633 |
| Inventories | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | - | 159.931 | 484.983 | 232.675 |
| Cash | - | - | - | - | - | - | - | 1.150 | 704 | 958 |
| Shareholders Funds | - | - | - | - | - | - | - | 63.326 | 180.613 | 113.192 |
| Social Capital | - | - | - | - | - | - | - | 0 | 20.216 | 20.103 |
| Debts | - | - | - | - | - | - | - | 29.850 | 318.012 | 153.612 |
| Income in Advance | - | - | - | - | - | - | - | 85.167 | 4.245 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7210 - 7210" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Crab Ray Doc S.r.l.